HOME >> BIOLOGY >> NEWS
US Presidential Candidates' Forum

WASHINGTON, DC - On September 30, AAAS will host a special Candidates' Forum on Science & Technology Policy, at which representatives of the U.S. presidential campaigns of incumbent George W. Bush and challenger John Kerry will discuss their plans and policies for science and technology.

The Forum will take place in the AAAS Auditorium, 12th and H Streets, N.W., Washington, DC, from 1 to 2:30 p.m. on Thursday, September 30, 2004.

Former House Science Committee Chairman Bob Walker will represent the Bush campaign. Mr. Walker is chairman of Wexler & Walker Public Policy Associates and has been described as "perhaps the best political and policy strategist and tactician in Washington." Speaking on behalf of the Kerry-Edwards campaign will be Henry Kelly. Dr. Kelly, a physicist, is former assistant director for technology of the White House Office of Science and Technology Policy. He is currently president of the Federation of American Scientists. Mary Woolley, president of Research!America, will moderate the event.

Each speaker will have the opportunity to make a short opening statement. The rest of the time will be devoted to Q&A.

This event is sponsored by the Washington Science Policy Alliance, a loosely-knit coalition of institutions that has banded together to conduct seminars and meetings around specific science and technology policy issues.

WHAT:
AAAS Candidates' Forum on Science & Technology Policy

WHO:
Bob Walker, former House Science Committee Chairman for George W. Bush and Henry Kelly, former assistant director for technology of the White House Office of Science and Technology Policy for John Kerry

WHEN:
30 September 2004, 1:00 - 2:30 PM.

WHERE:
AAAS Auditorium, 2nd floor
12th & H Streets, NW
Washington, DC 20005

R
'"/>

Contact: Monica Amarelo or Carol Hoy
mamarelo@aaas.org
202-326-6431
American Association for the Advancement of Science
24-Sep-2004


Page: 1 2

Related biology news :

1. AAAS US Presidential Candidates Forum
2. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
3. NJIT professor receives Presidential Award for breakthrough research with adult stem cells
4. Presidential Recognition Awards presented at the 2004 AIUM Annual Convention
5. DuPont receives US EPAs Presidential Green Chemistry Award for new innovation
6. Louisiana researcher and Washington, Pennsylvania, North Carolina companies win Presidential awards for environmentally-conscious business innovation
7. White House honors Hutchinson Center Scientist with Presidential Early Career Award
8. NSF-Supported New Scientists And Engineers Receive Presidential Award
9. Third Annual Awards For Presidential Green Chemistry Challenge Recognize Innovations
10. Victoria Hale of Institute for OneWorld Health Named Fellow by International Womens Forum
11. Webcast will ensure broad public access to the UC Santa Cruz Public Forum on Human Genome Research

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Presidential Candidates Forum

(Date:5/21/2013)... in pharmacies and health stores, phosphatidylserine is a ... soy. Proven to improve cognition and slow memory ... experiencing memory impairment. Now a team headed by ... Tel Aviv University,s Department of Human Molecular ... improves the functioning of genes involved in degenerative ...
(Date:5/21/2013)... gathering of biomass experts , Where? ... When? 03-07 June 2013 , ... resource assessment, market and policy developments, manufacturing and installation, ... and benefiting from its 2013 edition from a record ... 60 countries, more than 240 plenary and oral presentations, ...
(Date:5/20/2013)... 2013) University of Minnesota Medical School researchers from ... with the University,s Brain Tumor Program, have developed a ... (MPNST) that allow them to discover new genes and ... research was published this week in the journal ... method, researchers in the lab of David Largaespada, Ph.D., ...
Breaking Biology News(10 mins):Common food supplement fights degenerative brain disorders 221st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4U of M researchers develop model for better testing, targeting of MPNST 2
(Date:5/21/2013)... -- Personal Genome Diagnostics Inc. (PGDx), today announced that ... in genomic analysis of defined cancer subtypes to ... Medicines.  PGDx is an innovator in conducting patient-specific ... and Blueprint Medicines is an expert in developing ... patient population. "This collaboration brings together ...
(Date:5/21/2013)... CA (PRWEB) May 21, 2013 ... at the University of California, San Diego for a ... load bearing Gravitic™ MRI (Magnetic Resonance Imaging) with that ... renowned for its continued pursuit of improved healthcare by ... Spinal MRI is an extremely valuable tool for evaluating ...
(Date:5/21/2013)... Clinovo's new “CDISC Standards: Theory and Application” ... June 11th, 2013. The TechTrainings are technical hands-on classes ... step in their professional career. The class will be ... online. , Taught by Sy Truong, President at Meta-Xceed ... Theory and Application” class will give an overview of ...
(Date:5/20/2013)... -- Today, at the American Psychiatric Association (APA) Meeting ... James McGough , M.D., M.S., principal investigator and ... Neuroscience and Human Behavior and David Geffen ... California Los Angeles (UCLA), and director of clinical teaching ... at UCLA, presented the results of a Phase I ...
Breaking Biology Technology:Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3Vital Imaging Makes Greater Commitment into MRI Research 2Vital Imaging Makes Greater Commitment into MRI Research 3Clinovo Launches TechTrainings on CDISC Standards 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5
Cached News: